Shizheng Huang

Shizheng Huang

Auto-generated profile, based on publicly available information

Shizheng Huang

Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2018 in Science
Verified
Journal Article
Closed access
PDF file
JPJihwan Park
Jihwan Park
RSRojesh Shrestha
Rojesh Shrestha
CQChengxiang Qiu
Chengxiang Qiu
AKAyano Kondo
Ayano Kondo
SHShizheng Huang
Shizheng Huang
KSKatalin Suszták
Katalin Suszták
Touring the kidney, cell by cell: Our kidneys play a critical role in keeping us healthy, a fact of which we are reminded several times each day. This organ's cellular complexity has hindered progress in understanding the mechanisms underlying chronic kidney disease, which affects 10% of the world's population. Using single-cell transcriptional profiling, Park et al. produced a comprehensive cell atlas of the healthy mouse kidney (see the Perspective by Humphreys). An unexpected cell type in the collecting duct appears to be a transitional state between two known cell types. The transition from one cell type to the other is regulated by the Notch signaling pathway and is associated with metabolic acidosis. The authors also find that genetically distinct kidney diseases with common clinical features share common cellular origins. Science , this issue p. 758 ; see also p. 709

3 May 2016 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
MEMaria Edeling
Maria Edeling
GRGrace Ragi
Grace Ragi
SHShizheng Huang
Shizheng Huang
HPHermann Pavenstädt
Hermann Pavenstädt
KSKatalin Susztak
Katalin Susztak

1 October 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CQChengxiang Qiu
Chengxiang Qiu
SHShizheng Huang
Shizheng Huang
JPJihwan Park
Jihwan Park
YPYoSon Park
YoSon Park
YKYi-An Ko
Yi-An Ko
KSKatalin Susztak
Katalin Susztak

1 February 2016 in Cell Reports
Verified
Journal Article
Open access
HKHyun Mi Kang
Hyun Mi Kang
SHShizheng Huang
Shizheng Huang
KRKimberly Reidy
Kimberly Reidy
SHSeung Hyeok Han
Seung Hyeok Han
FCFrank Chinga
Frank Chinga
KSKatalin Susztak
Katalin Susztak
The kidney has a tremendous capacity to regenerate following injury, but factors that govern this response are still largely unknown. We isolated cells from mouse kidneys with high proliferative and multi-lineage differentiation capacity. These cells expressed a high level of Sox9. In regenerating kidneys, Sox9 expression was induced early, and 89% of proliferating cells were Sox9 positive. In vitro, Sox9-positive cells showed unlimited proliferation and multi-lineage differentiation capacity. Using an inducible Sox9 Cre line and lineage-tagging methods, we show that Sox9-positive cells can generate new daughter cells, contributing to the regeneration of proximal tubule, loop of Henle, and distal tubule segments but not to collecting duct and glomerular cells. Furthermore, inducible deletion of Sox9 resulted in reduced epithelial proliferation, more severe injury, and fibrosis development. In summary, we demonstrate that, in the kidney, Sox9-positive cells show progenitor-like properties in vitro and contribute to epithelial regeneration following injury in vivo.

1 June 2017 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YKYi-An Ko
Yi-An Ko
HYHuiguang Yi
Huiguang Yi
CQChengxiang Qiu
Chengxiang Qiu
SHShizheng Huang
Shizheng Huang
JPJihwan Park
Jihwan Park
KSKatalin Susztak
Katalin Susztak

24 January 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Xiaoyan ZhangXiaoyan Zhang
Xiaoyan Zhang
SHShizheng Huang
Shizheng Huang
MGMin Gao
Min Gao
JLJia Liu
Jia Liu
XJXiao Jia
Xiao Jia
YGYoufei Guan
Youfei Guan
The farnesoid X receptor (FXR) is a ligand-activated transcription factor belonging to the nuclear receptor superfamily. FXR is mainly expressed in liver and small intestine, where it plays an important role in bile acid, lipid, and glucose metabolism. The kidney also has a high FXR expression level, with its physiological function unknown. Here we demonstrate that FXR is ubiquitously distributed in renal tubules. FXR agonist treatment significantly lowered urine volume and increased urine osmolality, whereas FXR knockout mice exhibited an impaired urine concentrating ability, which led to a polyuria phenotype. We further found that treatment of C57BL/6 mice with chenodeoxycholic acid, an FXR endogenous ligand, significantly up-regulated renal aquaporin 2 (AQP2) expression, whereas FXR gene deficiency markedly reduced AQP2 expression levels in the kidney. In vitro studies showed that the AQP2 gene promoter contained a putative FXR response element site, which can be bound and activated by FXR, resulting in a significant increase of AQP2 transcription in cultured primary inner medullary collecting duct cells. In conclusion, the present study demonstrates that FXR plays a critical role in the regulation of urine volume, and its activation increases urinary concentrating capacity mainly via up-regulating its target gene AQP2 expression in the collecting ducts. Significance Farnesoid X (FXR) receptor is a ligand-activated transcription factor that regulates bile acid, lipid and glucose metabolism. It can be activated by endogenous bile acids, including chenodeoxycholic acid. This study uncovers a unique role for FXR to regulate urine volume independently of antidiuretic hormone and identifies aquaporin 2 as a direct target gene of FXR in renal collecting ducts. These findings provide a unique mechanism involved in the regulation of urinary concentrating process. The present study may also help understand the pathogenesis of hepatorenal syndrome, a state with increased circulating bile acid levels and impaired renal function.